Key facts
- This page summarizes Corleen M. Roche's Form 4 filing for CG Oncology, Inc. (CGON).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Apr 2025, 16:15.
Corleen M. Roche - 15 Apr 2025 Form 4 Insider Report for CG Oncology, Inc. (CGON)
- SEC form
- 4
- Accepted by SEC
- 16 Apr 2025, 16:15:09 UTC
- Prior SEC filing
- 08 Oct 2024
- Next SEC filing
- 08 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua F. Patterson, Attorney-in-Fact for Corleen Roche
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Corleen M. Roche filed Form 4 for CG Oncology, Inc. (CGON) on 16 Apr 2025.
Change
- Previous filing in this sequence was filed on 08 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CGON
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +143,907
- Change %
- Price
- $0.000000
- Shares after
- 143,907
- Date
- 15 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 143,907
- Exercise price
- $20.11
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date.